CVE-2026-52866 PUBLISHED

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization

Assigner: icscert
Reserved: 10.06.2026 Published: 18.06.2026 Updated: 18.06.2026

An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.

CVSS Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS Score: 6.5

Attack Vector	Adjacent Network	Scope	Unchanged
Attack Complexity	Low	Confidentiality Impact	None
Privileges Required	None	Integrity Impact	None
User Interaction	None	Availability Impact	High

CVSS 3.1

CVSS Vector: CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N
CVSS Score: 7.1

Exploitability Metrics		Vulnerable System Impact Metrics		Subsequent System Impact Metrics
Attack Vector	Adjacent	Confidentiality	None	Confidentiality	None
Attack Complexity	Low	Integrity	None	Integrity	None
Attack Requirements	None	Availability	High	Availability	None
Privileges Required	None
User Interaction	None

CVSS 4.0

Product Status

Vendor	Apollo Pharmacy
Product	Blood Glucose Monitoring System (Model No. APG-01 BT)
Versions	Default: unaffected Version 0x0110_v1.1.0 is affected

Workarounds

Apollo Pharmacy did not respond to CISA's requests to coordinate. Users are encouraged to reach out to Apollo Pharmacy directly for more information: https://www.apollopharmacy.in/contact-us

CISA recommends users follow the guidance in the Understanding Bluetooth Technology blog: https://www.cisa.gov/news-events/news/understanding-bluetooth-technology

Credits

Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA. finder

References

Problem Types

CWE-862 CWE